» Articles » PMID: 32278616

[Recommendations on Management of the SARS-CoV-2 Coronavirus Pandemic (Covid-19) in Kidney Transplant Patients]

Abstract

The SARS-CoV-2 (Covid-19) coronavirus pandemic is evolving very quickly and means a special risk for both immunosuppressed and comorbid patients. Knowledge about this growing infection is also increasing although many uncertainties remain, especially in the kidney transplant population. This manuscript presents a proposal for action with general and specific recommendations to protect and prevent infection in this vulnerable population such as kidney transplant recipients.

Citing Articles

Remdesivir: treatment of COVID-19 in special populations.

Molaei E, Molaei A, Wallace Hayes A, Karimi G Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(6):3829-3855.

PMID: 38180557 DOI: 10.1007/s00210-023-02927-2.


Right lower lobectomy in a post-renal transplant patient with covid associated mucormycosis and a mycotic aneurysm in the pulmonary circulation.

Arora P, Bais S, Singha S Ann Card Anaesth. 2023; 26(3):353-355.

PMID: 37470541 PMC: 10451122. DOI: 10.4103/aca.aca_118_22.


Disease Course, Management and Outcomes in Kidney Transplant Recipients with SARS-CoV-2 Infection during the Omicron-Variant Wave: A Single-Center Experience.

Korogiannou M, Vallianou K, Xagas E, Rokka E, Soukouli I, Boletis I Vaccines (Basel). 2023; 11(3).

PMID: 36992215 PMC: 10054376. DOI: 10.3390/vaccines11030632.


[Update of the recommendations on the management of the SARS-CoV-2 coronavirus pandemic (COVID-19) in kidney transplant patients.].

Lopez V, Mazuecos A, Villanego F, Lopez-Oliva M, Alonso A, Beneyto I Nefrologia. 2022; .

PMID: 36405492 PMC: 9664833. DOI: 10.1016/j.nefro.2022.11.001.


Remdesivir in kidney transplant patients with SARS-CoV-2 pneumonia.

Cacho J, Burgos E, Molina M, Villegas A, Perez M, Canas L Nefrologia (Engl Ed). 2022; 42(3):311-317.

PMID: 36210620 PMC: 9343742. DOI: 10.1016/j.nefroe.2022.07.006.


References
1.
Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G . A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med. 2020; 382(19):1787-1799. PMC: 7121492. DOI: 10.1056/NEJMoa2001282. View

2.
Kumar D, Tellier R, Draker R, Levy G, Humar A . Severe Acute Respiratory Syndrome (SARS) in a liver transplant recipient and guidelines for donor SARS screening. Am J Transplant. 2003; 3(8):977-81. PMC: 7175989. DOI: 10.1034/j.1600-6143.2003.00197.x. View

3.
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J . A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020; 382(8):727-733. PMC: 7092803. DOI: 10.1056/NEJMoa2001017. View

4.
Ruan Q, Yang K, Wang W, Jiang L, Song J . Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020; 46(5):846-848. PMC: 7080116. DOI: 10.1007/s00134-020-05991-x. View

5.
Xu X, Han M, Li T, Sun W, Wang D, Fu B . Effective treatment of severe COVID-19 patients with tocilizumab. Proc Natl Acad Sci U S A. 2020; 117(20):10970-10975. PMC: 7245089. DOI: 10.1073/pnas.2005615117. View